929006-75-7

Upstream product

• 929006-70-2 (6S,7R)-6-(dibenzylamino)-2,2,13,13,14,14-hexamethyl-3,3-diphenyl-4,12-dioxa-3,13-disilapentadec-9-yn-7-ol 
• 929006-86-0 (4R,5S)-N,N-dibenzyl-4-(((2S,3S)-3-((tert-butyldimethylsilyloxy)methyl)oxiran-2-yl)methyl)-2,2-dimethyl-1,3-dioxan-5-amine 
• 929006-84-8 4-((4R,5S)-5-(dibenzylamino)-2,2-dimethyl-1,3-dioxan-4-yl)but-2-yn-1-ol 
• 929006-71-3 (E)-4-((4R,5S)-5-(dibenzylamino)-2,2-dimethyl-1,3-dioxan-4-yl)but-2-en-1-ol 
• 929006-83-7 (2S,3R)-2-(dibenzylamino)hept-5-yne-1,3,7-triol 
• 929006-73-5 ((2S,3S)-3-(((4R,5S)-5-(dibenzylamino)-2,2-dimethyl-1,3-dioxan-4-yl)methyl)oxiran-2-yl)methanol 

Downstream Products

• 929007-03-4 (2R,3S,5R,6S)-2-azido-6-(dibenzylamino)heptane-1,3,5,7-tetraol 
• 929007-04-5 (26,7S,9R,10S)-6-azido-10-(dibenzylamino)-2,2,14,14-tetramethyl-3,3,13,13-tetraphenyl-4,12-dioxa-3,13-disilapentadecane-7,9-diol 
• 1227044-45-2 C₄₀H₅₀N₄O₄Si 

Relevant academic research and scientific papers

Asymmetric synthesis of diastereomeric diaminoheptanetetraols. A proposal for the configuration of (+)-zwittermicin A

A proposed absolute configuration for the 7 stereocenters in (+)-zwittermicin A is described based on asymmetric synthesis of six diastereomeric 2,6-diamino-1,3,5,7-heptanetetraols corresponding to the C9-C15 segment, pairwise 13C NMR chemical